Ganciclovir Completed Phase 4 Trials for Infections, Cytomegalovirus / Infections, Herpesviridae / DNA Virus Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00373165Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients